[EN] COMPOUNDS USEFUL IN THE TREATMENT OR PREVENTION OF A PRMT5-MEDIATED DISORDER [FR] COMPOSÉS UTILES POUR TRAITER OU PRÉVENIR UN TROUBLE INDUIT PAR PRMT5
COMPOUNDS USEFUL IN THE TREATMENT OR PREVENTION OF A PRMT5-MEDIATED DISORDER
申请人:ARGONAUT THERAPEUTICS LIMITED
公开号:US20200325128A1
公开(公告)日:2020-10-15
The present disclosure relates to compounds suitable for the inhibition of protein arginine methyl-transferase (PRMT), in particular PRMT5. These compounds may be for use as therapeutic agents, in particular, agents for use in the treatment and/or prevention of proliferative diseases, such as cancer.